Advait is, Senior Director- Pharmaceutics R&D Pfizer’s within Pfizer’s Biotherapeutics Pharmaceutical Sciences organization responsible for Novel Delivery Technologies to support Pfizer’s entire biotherapeutics portfolio (including, but not limited to- mammalian and microbial fermentation derived candidate molecules, vaccines, gene medicine and cell-based therapies, targeted delivery strategies, and novel delivery device development). The group supports early-stage Research all the way through Commercial and post-Commercial life-cycle management where the emphasis is on providing risk-based solutions for portfolio enabling drug delivery technologies, with an eye on clinical and commercial development feasibility. Advait has held roles of increasing responsibilities and complexities over his 18+ years career at Pfizer. Prior to the current position, Advait was the Director- Bioprocess R&D Technology, Pfizer Inc., where he was accountable for the Technology Strategy and Operations for investment across drug substance, drug product and analytical areas. Before this role, he held the position of Group Leader- Drug Product Formulation & Process Development, Pfizer Inc. Advait received his Ph.D. in Pharmaceutical Sciences from the College of Pharmacy and Health Sciences, Mercer University (Atlanta, GA) and a MS in Pharmaceutics from Auburn University, Auburn, AL. He also has a BS in Pharmacy from Pune University (India). He is a member of AAPS and Controlled Release Society and has authored 3 patents, published over 25 articles in professional scientific journals, and presented more than 50 short papers, posters and talks.